We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Next Gen Technology Enables Robust, Straightforward and Flexible Molecular Diagnostics in Any Environment

By LabMedica International staff writers
Posted on 24 Mar 2023
Print article
Image: The novel technology uses fringe-field capacitive sensing to quantify molecular targets (Photo courtesy of AltraTech)
Image: The novel technology uses fringe-field capacitive sensing to quantify molecular targets (Photo courtesy of AltraTech)

The implementation of point-of-care systems is often hindered by challenges related to sample preparation, reagent storage, and user proficiency. Now, a next-generation ‘Anywhere, anytime, by anyone’ molecular detection technology aims to shift the detection and monitoring of viral infections to point-of-care and beyond clinical settings. The technology, which allows for rapid and precise measurement and quantification of viral RNA, DNA, antigens, or antibodies, can be used by anyone, anywhere, at any time.

AltraTech Limited’s (Cork, Ireland) innovative technology integrates nanotechnology, semiconductor technology, and novel PNA chemistry to create a distinct and robust assay. This assay, called Molecular Detection by Proxy, is a bead-based technology that employs ultra-sensitive capacitance detection. The assay involves three critical stages. The first stage uses exclusive bioorthogonal PNAs to overcome the challenge of extracting genetic material from a biological sample without any sample preparation. These synthetic nucleic acids are incredibly specific and can be directly introduced into the sample.

The target is then captured onto a magnetic bead, following which the captured molecules are magnetically removed from the sample and tethered onto coded nanoparticles. These nanoparticles are representative of the biological target, with each particle equivalent to a single target. Finally, the particles are released over a highly sensitive, bioorthogonal CMOS biosensor chip, resulting in a change of capacitance. The higher the number of particles, the greater the measured capacitance, leading to a linear correlation with the initial target present in the sample.

As a result, the assay can be multiplexed with ease and used to measure other targets, including antibodies or antigens, within the same test. Moreover, as soon as a new genome is accessible, the company’s core bioorthogonal PNA chemistry can be promptly programmed with the specific targeting sequences, enabling a new test to be deployed within days. The assay will be integrated into a solid-state device that can be miniaturized, commercialized, and mass-produced.

Related Links:
AltraTech Limited 

Flocked Swab
HydraFlock and PurFlock Ultra
Gold Supplier
Automated, Random Access Chemistry Analyzer
LIDA 300
New
Silver Supplier
HSV1+2 / VZV Test
Savvygen HSV1+2 / VZV
New
SARS-CoV-2 Test
BioCode SARS-CoV-2 Assay

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Molecular Diagnostics

view channel
Image: A portable smartphone-based POC device for use with EXTRA-CRISPR method for cancer diagnostics (Photo courtesy of UF Health)

CRISPR-Powered Method for Non-Invasive Blood Tests to Help Diagnose Early Stage Cancer

MicroRNAs, tiny RNA molecules that regulate gene expression, have been identified as potential cancer biomarkers in human fluids like blood. Extracellular vesicles, tiny particles actively discharged by... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

Injury or surgery naturally creates bleeding in living beings, which must be stopped to prevent excessive blood loss. The human body implements a protective mechanism known as hemostasis to stop excessive bleeding.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.